Assenagon Asset Management
CRDF icon

Assenagon Asset Management’s Cardiff Oncology CRDF Stock Holding History

Assenagon Asset Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.4K Hold
67,231
– – ﹤0.01% 1154
2026
Q1 		$109K Hold
67,231
– – ﹤0.01% 1084
2025
Q4 		$189K Hold
67,231
– – ﹤0.01% 1122
2025
Q3 		$138K Hold
67,231
– – ﹤0.01% 1141
2025
Q2 		$212K Hold
67,231
– – ﹤0.01% 1117
2025
Q1 		$211K Hold
67,231
– – ﹤0.01% 1102
2024
Q4 		$292K Sell
67,231
-203,292
-75% -$635K ﹤0.01% 1247
2024
Q3 		$722K Sell
270,523
-945,399
-78% -$2.23M ﹤0.01% 1182
2024
Q2 		$2.7M Buy
1,215,922
+962,940
+381% +$3.63M 0.01% 810
2024
Q1 		$1.35M Buy
+252,982
New +$672K ﹤0.01% 989
2023
Q4 		– Sell
-84,272
Closed -$117K – 1421
2023
Q3 		$117K Sell
84,272
-58,156
-41% -$98.1K ﹤0.01% 1351
2023
Q2 		$209K Sell
142,428
-252,566
-64% -$407K ﹤0.01% 1279
2023
Q1 		$652K Buy
394,994
+215,451
+120% +$370K ﹤0.01% 1163
2022
Q4 		$251K Buy
179,543
+13,009
+8% +$18.6K ﹤0.01% 1285
2022
Q3 		$256K Buy
166,534
+11,344
+7% +$27.3K ﹤0.01% 1241
2022
Q2 		$341K Sell
155,190
-169,270
-52% -$283K ﹤0.01% 1306
2022
Q1 		$805K Buy
+324,460
New +$1.15M ﹤0.01% 1109
2021
Q3 		– Sell
-26,167
Closed -$174K – 1312
2021
Q2 		$174K Buy
+26,167
New +$222K ﹤0.01% 1153

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Assenagon Asset Management's CRDF Position: Q2 2026 in Review

Assenagon Asset Management held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 67,231 shares worth $87.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

Assenagon Asset Management first reported a position in CRDF in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.7M in Q2 2024. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Assenagon Asset Management held 67,231 shares of Cardiff Oncology worth $87.4K as of Q2 2026.
  • Assenagon Asset Management left its Cardiff Oncology share count unchanged in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1154 holding.
  • Assenagon Asset Management first reported a position in Cardiff Oncology in Q2 2021 and has held it in 18 quarters since.
  • Assenagon Asset Management's Cardiff Oncology position peaked at $2.7M in Q2 2024.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.